Teligent (Teligent) Other Current Liabilities : $0.00 Mil (As of Jun. 2021)

View and export this data going back to 1997. Start your Free Trial

What is Teligent Other Current Liabilities?

Teligent's other current liabilities for the quarter that ended in Jun. 2021 was $0.00 Mil.

Teligent Other Current Liabilities Historical Data

The historical data trend for Teligent's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teligent Other Current Liabilities Chart

Teligent Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Other Current Liabilities

Get a 7-Day Free Trial

Teligent Quarterly Data
	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Teligent Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Teligent Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Teligent's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Teligent (Teligent) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teligent Inc (OTCPK:TLGTQ) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

105 Lincoln Avenue, Buena, NJ, USA, 08310

Website

https://www.teligent.com

Teligent Inc is a specialty generic pharmaceutical company. Teligent develops, manufactures, and sells (under its own label) topical, injectable, complex, and ophthalmic pharmaceutical products in the U.S. and Canada. The product portfolio consists of hospital-based sterile injectable products and topical products (creams like Synalar and Spectazole; lotions like Kenalog; ointments like Topicort and Kenalog; and topical solutions like Pennsaid and Xylocaine). The company also offers services to the pharmaceutical, over-the-counter, and cosmetic markets.

Executives

Joseph Benesch	officer: VP, Controller, PAO	C/O TELIGENT, 105 LINCOLN AVENUE, BUENA NJ 08310
Alyssa Lozynski	officer: Interim CFO	C/O TELIGENT, INC. 105 LINCOLN AVENUE BUENA NJ 08310
William S Marth	director	236 GROVE STREET, WELLESLEY MA 02482
Philip K Yachmetz	officer: EVP, Chief Legal Off, Corp Sec	501 LAFAYETTE AVE WYCKOFF NJ 07481
R Carter Pate	director	5739 WORTHAM LANE, DALLAS TX 75252
De Paolantonio Ernest Robert	officer: Chief Financial Officer	4131 PARKLAKE AVENUE SUITE 225, RALEIGH NC 27612
Carole Ben-maimon	director	C/O IMPAX LABORATORIES, INC., 30831 HUNTWOOD AVENUE, HAYWARD CA 94544
Bhaskar Chaudhuri	director	ONE ENTERPRISE, ALISO VIEJO CA 92656
Sabatino Thomas J Jr	director	C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015
John E Celentano	director	C/O IGI LABORATORIES, INC., 105 LINCOLN AVENUE, BUENA NJ 08310
Steven H Koehler	director	C/O THE MEDICINES CO, 5 SYLVAN WAY, PARSIPPANY NJ 07054
Keith James	officer: Prin Acct Officer Controller	105 LINCOLN AVENUE BUENA NJ 08310
Life Sciences Opportunities Fund Ii Lp	10 percent owner	152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019
Donald V Weir	10 percent owner	SANDERS MORRIS HARRIS, 600 TRAVIS, HOUSTON TX 77002
Timothy B. Sawyer	officer: CEO	C/O TELIGENT, INC. 105 LINCOLN AVENUE BUENA NJ 08310